Bottom line
GMIQX vs GMCFX: the short answer
GMIQX (GMO Multi-Asset Credit Fund) and GMCFX (GMO International Equity Fund) are both mutual funds.
But GMCFX is far broader, holding 192 positions to 8 for GMIQX, so beyond the top names it adds exposure GMIQX doesn't have.
GMCFX is cheaper at 0.62% vs 0.69% — a difference of $7.00 a year per $10,000 invested.
Updated Nov 19, 2026
GMIQX vs GMCFX side by side
| GMIQX | GMCFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Gmo | Gmo |
| Category | Allocation / Balanced | International Stock |
| Expense ratio | 0.69% | 0.62% |
| Annual cost per $10k | $69 | $62 |
| 10-yr cost on $10k (prospectus) | $1,430 | $819 |
| Max front load | — | — |
| 12b-1 fee | — | — |
| 1-yr return | — | +44.1% |
| 5-yr return (annualized) | — | +14.6% |
| 10-yr return (annualized) | — | +10.4% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $203.5M | $1.4B |
| Number of holdings | 8 | 192 |
| Portfolio turnover | 42% | 104% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
1 of GMIQX's top 8 holdings also appear in GMCFX's top 25.
| Holding | GMIQX | GMCFX |
|---|---|---|
| GMO US Treasury Fund | 2.12% | 4.81% |
Source: SEC Form N-PORT
GMIQX top 10
- GMO Opportunistic Income Fund — 44.72%
- GMO High Yield Fund — 12.49%
- GMO Emerging Country Debt — 12.13%
- GMO MAC Implementation Fund — 10.89%
- GMO Systematic Investment Grade Credit ETF — 9.38%
- GMO Ultra-Short Income ETF — 7.12%
- GMO US Treasury Fund — 2.12%
- State Street Global Advisors — 0.97%
GMCFX top 10
- GMO US Treasury Fund — 4.81%
- ASML Holding NV — 4.60%
- Nokia Oyj — 2.90%
- Panasonic Holdings Corp — 2.79%
- Rio Tinto PLC — 2.66%
- ABB Ltd — 2.55%
- Banco Bilbao Vizcaya Argentaria SA — 2.46%
- Deutsche Post AG — 2.25%
- Vodafone Group PLC — 2.20%
- Murata Manufacturing Co Ltd — 2.11%
FAQ
What is the difference between GMIQX and GMCFX?
Which is cheaper, GMIQX or GMCFX?
Should I own both GMIQX and GMCFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.